High Granular Tick Data API: US Stocks Learn more

Try our APIs with free plan!

Lakefront Biotherapeutics NV Financial Data Overview

Price chart is built with Anychart

Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667, which is in a phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in a phase 1/2 trial in relapsed/refractory non-hodgkin lymphoma; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc. The company was formerly known as Galapagos NV and changed its name to Lakefront Biotherapeutics NV in May 2026. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium.

Prev. Close 27.0013
Open 27.1726
High 27.2203
Low 26.6873
52 wk Range 25.68-37.78
Market Cap 1 756 M
P/E Ratio 2.5582
Shares Outstanding 65 485 K
Revenue 991 M
EPS 0.03
Beta 0.116

* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.


ETFs with Lakefront Biotherapeutics NV (top by weight)

Ticker
100-day Price Change
Weight
IBB.US iShares Biotechnology ETF
31.52 (18.39%)
0.08
BTEC.SW iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) USD
1.42 (16.36%)
0.03

* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.


Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Lakefront Biotherapeutics NV data using free add-ons & libraries


Get Lakefront Biotherapeutics NV Fundamental Data

Lakefront Biotherapeutics NV Fundamental data includes:

  • Net Revenue: 991 M
  • EBITDA: 569 M
  • Earnings Per Share: 10
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Lakefront Biotherapeutics NV Earnings data

Corporate Events Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2026-08-10
  • EPS/Forecast: -11.5
GET THE PACKAGE

Get Lakefront Biotherapeutics NV End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE

Lakefront Biotherapeutics NV News

Get Lakefront Biotherapeutics NV fresh news feed via Financial News API

Corporate Events Calendar & News package for

$19.99/mo.

Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Live chat support

Send the request

Leave your email and our team will contact you ASAP.